Table 6.

Monocyte and MDSC subsets pre-exercise, post-exercise, and 30-min post-exercise in participants with smouldering multiple myeloma, with percentage change (%Δ) pre-to post-exercise and main effect of time from repeated measures ANOVA. Data are mean ± SD, n = 8.

Cells/μL	Phenotype	Pre-exercise	Post-exercise	30-min post-exercise	%Δ Pre-Post	Main effect of time
Non-classical	HLA-DR + CD14dimCD16+	32 ± 17	63 ± 29b	31 ± 19e	125 ± 89	F(2,14) = 21.73, p < 0.001, ηp2 = 0.76
Intermediate	HLA-DR+CD14+CD16+	32 ± 17	46 ± 20b	29 ± 14d	48 ± 26	F(2,14) = 11.98, p < 0.001, ηp2 = 0.63
Classical	HLA-DR+CD14+CD16−	275 ± 52	388 ± 106a	271 ± 69e	41 ± 24	F(2,14) = 17.00, p < 0.001, ηp2 = 0.71
Effector	HLA-DR+CD14+CD32+	322 ± 78	458 ± 153a	311 ± 88d	41 ± 26	F(1.19,8.34) = 12.72, p = 0.006, ηp2 = 0.65
MDSCs	HLA-DR−CD33+	62 ± 22	90 ± 27c	62 ± 22f	49 ± 23	F(1.07,7.47) = 46.80, p < 0.001, ηp2 = 0.87
M-MDSCs	HLA-DR−CD33+CD14+	21 ± 21	28 ± 36	19 ± 17	17 ± 63	F(1.02,7.15) = 1.17, p = 0.32, ηp2 = 0.14
PMN-MDSCs	HLA-DR−CD33+CD14−	41 ± 27	58 ± 31	42 ± 25	43 ± 45	F(1.03,7.18) = 6.12, p = 0.041, ηp2 = 0.47

ANOVA, analysis of variance; MDSCs, myeloid-derived suppressor cells; M-MDSCs, monocytic myeloid-derived suppressor cells; PMN-MDSCs, polymorphonuclear myeloid-derived suppressor cells.

^aindicates a significant difference from pre-exercise at p < 0.05.

^bindicates a significant difference from pre-exercise at p < 0.01.

^cindicates a significant difference from pre-exercise at p < 0.001.

^dindicates a significant difference from post-exercise at p < 0.05.

^eindicates a significant difference from post-exercise at p < 0.01.

^findicates a significant difference from post-exercise at p < 0.001.